Endothelial-specific deletion of Ets-1 attenuates Angiotensin II-induced cardiac fibrosis via suppression of endothelial-to-mesenchymal transition
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Cardiac fibrosis is a common feature in chronic hypertension patients with advanced heart failure, and endothelial-tomesenchymal transition (EndMT) is known to promote Angiotensin II (Ang II)-mediated cardiac fibrosis. Previous studies have suggested a potential role for the transcription factor, ETS-1, in Ang II-mediated cardiac remodeling, however the mechanism are not well defined. In this study, we found that mice with endothelial Ets-1 deletion showed reduced cardiac fibrosis and hypertrophy following Ang II infusion. The reduced cardiac fibrosis was accompanied by decreased expression of fibrotic matrix genes, reduced EndMT with decreased Snail, Slug, Twist, and ZEB1 expression, as well as reduced cardiac hypertrophy and expression of hypertrophyassociated genes was observed. In vitro studies using cultured H5V cells further confirmed that ETS-1 knockdown inhibited TGF-1-induced EndMT. This study revealed that deletion of endothelial Ets-1 attenuated Ang II-induced cardiac fibrosis via inhibition of EndMT, indicating an important ETS-1 function in mediating EndMT. Inhibition of ETS-1 could be a potential therapeutic strategy for treatment of heart failure secondary to chronic hypertension.
Abstract
Cardiac fibrosis is a common feature in chronic hypertension patients with advanced heart failure, and endothelial-tomesenchymal transition (EndMT) is known to promote Angiotensin II (Ang II)-mediated cardiac fibrosis. Previous studies have suggested a potential role for the transcription factor, ETS-1, in Ang II-mediated cardiac remodeling, however the mechanism are not well defined. In this study, we found that mice with endothelial Ets-1 deletion showed reduced cardiac fibrosis and hypertrophy following Ang II infusion. The reduced cardiac fibrosis was accompanied by decreased expression of fibrotic matrix genes, reduced EndMT with decreased Snail, Slug, Twist, and ZEB1 expression, as well as reduced cardiac hypertrophy and expression of hypertrophyassociated genes was observed. In vitro studies using cultured H5V cells further confirmed that ETS-1 knockdown inhibited TGF-1-induced EndMT. This study revealed that deletion of endothelial Ets-1 attenuated Ang II-induced cardiac fibrosis via inhibition of EndMT, indicating an important ETS-1 function in mediating EndMT. Inhibition of ETS-1 could be a potential therapeutic strategy for treatment of heart failure secondary to chronic hypertension.
참고문헌 (24)
- Gourdie RG, "Novel therapeutic strategies targeting fibroblasts and fibrosis in heart disease", Nat Rev Drug Discov, 15, pp.620~638 (2016)
- Furtado MB, "View from the heart : cardiac fibroblasts in development, scarring and regeneration", Development, 143, pp.387~397 (2016)
- Ho CY, "Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy", N Engl J Med, 363, pp.552~563 (2010)
- Piera-Velazquez S, "Role of endothelial-mesenchymal transition(EndoMT)in the pathogenesis of fibrotic disorders", Am J Pathol, 179, pp.1074~1080 (2011)
- Zeisberg EM, "Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition", J Am Soc Nephrol, 19, pp.2282~2287 (2008)
- Zeisberg EM, "Endothelial-to-mesenchymal transition contributes to cardiac fibrosis", Nat Med, 13, pp.952~961 (2007)
- Li Y, "Reassessing endothelialto-mesenchymal transition in cardiovascular diseases", Nat Rev Cardiol, 15, pp.445~456 (2018)
- Zhan Y, "Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling", J Clin Invest, 115, pp.2508~2516 (2005)
- Hao G, "Ets-1 upregulation mediates angiotensin II-related cardiac fibrosis", Int J Clin Exp Pathol, 8, pp.10216~10227 (2015)
- Ye M, "Deletion of ETS-1, a gene in the Jacobsen syndrome critical region, causes ventricular septal defects and abnormal ventricular morphology in mice", Hum Mol Genet, 19, pp.648~656 (2010)
- Li C, "Transcriptional silencing of ETS-1 abrogates epithelial-mesenchymal transition resulting in reduced motility of pancreatic cancer cells", Oncol Rep, 33, pp.559~565 (2015)
- Shirakihara T, "Differential regulation of epithelial and mesenchymal markers by deltaEF1 proteins in epithelial mesenchymal transition induced by TGF-beta", Mol Biol Cell, 18, pp.3533~3544 (2007)
- Okano K, "Inhibitory effects of the transcription factor Ets-1 on the expression of type I collagen in TGF-beta1-stimulated renal epithelial cells", Mol Cell Biochem, 369, pp.247~254 (2012)
- Wei WY, "Pioglitazone alleviates cardiac fibrosis and inhibits endothelial to mesenchymal transition induced by pressure overload", Cell Physiol Biochem, 45, pp.26~36 (2018)
- Koinuma D, "Chromatin immunoprecipitation on microarray analysis of Smad2", 3 binding sites reveals roles of ETS1 and TFAP2A in transforming growth factor beta signaling, 2009, pp.29, 172~186
- Czuwara-Ladykowska J, "Ets1 is an effector of the transforming growth factor beta(TGF-beta)signaling pathway and an antagonist of the profibrotic effects of TGF-beta", J Biol Chem, 277, pp.20399~20408 (2002)
- Millien G, "ETS1 regulates Twist1 transcription in a Kras(G12D)", Lkb1(-, Clin Exp Metastasis, pp.2018, 35[DOI]
- Sinh ND, "Ets1and ESE1 reciprocally regulate expression of ZEB1", ZEB2, dependent on ERK1, Cancer Sci, pp.2017, 108[DOI]
- Dave N, "Functional cooperation between Snail1 and twist in the regulation of ZEB1 expression during epithelial to mesenchymal transition", J Biol Chem, 286, pp.12024~12032 (2011)
- Ye M, "Gene-targeted deletion of OPCML and Neurotrimin in mice does not yield congenital heart defects", Am J Med Genet A, 164A, pp.966~974 (2014)
- Sheng LJ, "Beta3 adrenergic receptor is involved in vascular injury in deoxycorticosterone acetate-salt hypertensive mice", FEBS Lett, 590, pp.769~778 (2016)
- Lin JR, "Suppression of endothelial-to-mesenchymal transition by SIRT(Sirtuin)3alleviated the development of hypertensive renal injury", Hypertension, 72, pp.350~360 (2018)
- He D, "Anti-angiogenesis effect of trichosanthin and the underlying mechanism", Biochem Biophys Res Commun, 430, pp.735~740 (2013)
- Plotnik JP, "ETS1 is a genome-wide effector of RAS", ERK signaling in epithelial cells, 2014, pp.42, 11928~11940